Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001401825 | SCV001603659 | likely benign | Long QT syndrome | 2022-06-02 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402368 | SCV002704640 | likely benign | Cardiovascular phenotype | 2019-11-06 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003437225 | SCV004164297 | likely benign | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |